| 0 | ℹ |
Steatosis grade and cardiometabolic burden as determinants of hepatocellular carcinoma risk after hepatitis C cure in patients with metabolic dysfunction-associated steatotic liver disease.
(gut.bmj.com)
|
Gut 2026-01-20 | #metabolism #hepatocellular carcinoma #hepatitis c #fibrosis #steatosis | |
| 0 | ℹ |
Blood metabolic panels for identifying significant fibrosis and inflammation in patients with MASLD.
(linkinghub.elsevier.com)
|
Cell Reports Medicine 2026-01-20 | #modeling #metabolism #inflammation #biomarker #fibrosis |